Pharmaceutical company Galderma (UK) Limited has confirmed that aesthetic and skincare product supplier Med-fx Ltd will become the company’s preferred distributor, subject to contract, for its aesthetics portfolio.
Med-fx will service all customers who purchase under the Azzalure and Restylane brands in the UK and Republic of Ireland, the company explains, with the aim to offer an enhance level of customer service.
Galderma has confirmed that the new proposals are due to come into play, subject to contract, from September 8. In the interim, existing distributors will continue to be able to purchase and sell Galderma products and services. They will also be able to do so after September 8.
Toby Cooper, medical solutions business unit head of Galderma UK and Ireland commented, “We’re very pleased to be working with Med-fx on developing an improved proposition for our customers. They have a strong market standing and share our vision of being healthcare professionals’ trusted partners in making a positive difference in the lives of patients. I’m confident that working with Med-fx on a refined distribution model will allow us to enrich the relationships we have with our customers and we look forward to sharing details on the new proposition as soon as possible.”
Managing director of Med-fx, Paul Adams, added, “I am delighted to have the opportunity to partner with Galderma on an exciting journey to jointly develop a market-leading solution for healthcare professionals.”
